Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share

v3.22.2.2
Loss Per Share
9 Months Ended
Oct. 01, 2022
Earnings Per Share [Abstract]  
Loss Per Share

Note 18: Loss Per Share

Net loss per share is calculated using the weighted average number of shares of common stock outstanding during the applicable period. Basic weighted average common shares outstanding do not include shares of restricted stock that have not yet vested, although such shares are included as outstanding shares in the Company’s Consolidated Balance Sheet. Diluted net loss per share is computed using the weighted average number of common shares outstanding and if dilutive, potential common shares outstanding during the period. Potential common shares consist of the additional common shares issuable in respect of restricted share awards, stock options and convertible preferred stock. As discussed in Note 17 above, 16,141 shares of Series A-1 Preferred Stock were converted into 322,820 shares of the Company's common stock. For purposes of determining the weighted average common shares outstanding for the 13 weeks and 39 weeks ended October 1, 2022, respectively, these shares are considered to be outstanding for the entire period.

The following table presents the computation of basic and diluted net loss per share (in $000’s, except share and per–share data):

 

 

 

For the Thirteen Weeks Ended

 

 

For the Thirty-Nine Weeks Ended

 

 

 

October 1, 2022

 

 

October 2, 2021

 

 

October 1, 2022

 

 

October 2, 2021

 

Net income

 

$

(2,074

)

 

$

(968

)

 

$

9,824

 

 

$

(5,445

)

Basic

 

 

 

 

 

 

 

 

 

 

 

 

Basic income (loss) per share

 

$

(0.66

)

 

$

(0.34

)

 

$

3.12

 

 

$

(2.09

)

Weighted average common shares outstanding

 

 

3,150,230

 

 

 

2,827,410

 

 

 

3,150,230

 

 

 

2,601,827

 

Diluted

 

 

 

 

 

 

 

 

 

 

 

 

Diluted income (loss) per share

 

$

(0.66

)

 

$

(0.34

)

 

$

2.81

 

 

$

(2.09

)

Weighted average common shares outstanding

 

 

3,150,230

 

 

 

2,827,410

 

 

 

3,496,003

 

 

 

2,601,827

 

 

Potentially dilutive securities totaling 117,500 and 66,000 were excluded from the calculation of diluted earnings per share for the 39 weeks ended October 1, 2022 and October 2, 2021, respectively, because the effects were anti-dilutive based on the application of the treasury stock method. Additionally, 205,299 shares of Series A-1 Preferred Stock, convertible into 4,105,979 of the Company’s common shares, were excluded from the calculation of diluted earnings per share as, by agreement, these shares could not be converted as of October 1, 2022.